OBJECTIVE:Endocannabinoid system (ECS) activation promotes obesity-associated metabolic disease. Increased dietary fat intake increases blood endocannabinoids and alters adipose and skeletal muscle ECS gene expression in human. METHODS: Two weeks isocaloric low- (LFD) and high-fat diets (HFD) in obese (n = 12) and normal-weight (n = 17) subjects in a randomized cross-over study were compared. Blood endocannabinoids were measured in the fasting condition and after food intake using mass spectrometry. Adipose and skeletal muscle gene expression was determined using real-time RT-PCR. RESULTS:Baseline fasting plasma endocannabinoids were similar with both diets. Anandamide decreased similarly with high- or low-fat test meals in both groups. Baseline arachidonoylglycerol plasma concentrations were similar between groups and diets, and unresponsive to eating. In subcutaneous adipose tissue, DAGL-α mRNA was upregulated and fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) mRNAs were down-regulated in obese subjects, but the diets had no influence. In contrast, the HFD produced pronounced reductions in skeletal muscle CB1-R and MAGL mRNA expression, whereas obesity did not affect muscular gene expression. CONCLUSIONS: Weight-neutral changes in dietary fat intake cannot explain excessive endocannabinoid availability in human obesity. Obesity and dietary fat intake affect ECS gene expression in a tissue-specific manner.
RCT Entities:
OBJECTIVE: Endocannabinoid system (ECS) activation promotes obesity-associated metabolic disease. Increased dietary fat intake increases blood endocannabinoids and alters adipose and skeletal muscle ECS gene expression in human. METHODS: Two weeks isocaloric low- (LFD) and high-fat diets (HFD) in obese (n = 12) and normal-weight (n = 17) subjects in a randomized cross-over study were compared. Blood endocannabinoids were measured in the fasting condition and after food intake using mass spectrometry. Adipose and skeletal muscle gene expression was determined using real-time RT-PCR. RESULTS: Baseline fasting plasma endocannabinoids were similar with both diets. Anandamide decreased similarly with high- or low-fat test meals in both groups. Baseline arachidonoylglycerol plasma concentrations were similar between groups and diets, and unresponsive to eating. In subcutaneous adipose tissue, DAGL-α mRNA was upregulated and fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) mRNAs were down-regulated in obese subjects, but the diets had no influence. In contrast, the HFD produced pronounced reductions in skeletal muscle CB1-R and MAGL mRNA expression, whereas obesity did not affect muscular gene expression. CONCLUSIONS: Weight-neutral changes in dietary fat intake cannot explain excessive endocannabinoid availability in humanobesity. Obesity and dietary fat intake affect ECS gene expression in a tissue-specific manner.
Authors: Lenir C Correia; Jaderson V Ferreira; Henrique B de Lima; Guilherme M Silva; Carlos H T P da Silva; Fábio A de Molfetta; Lorane I S Hage-Melim Journal: J Mol Model Date: 2022-08-17 Impact factor: 2.172
Authors: Erin C Hanlon; Rachel Leproult; Kara L Stuhr; Elizabeth M Doncheck; Cecilia J Hillard; Eve Van Cauter Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958
Authors: Akhila Mallipedhi; Sarah L Prior; Gareth Dunseath; Richard M Bracken; Jonathan Barry; Scott Caplin; Nia Eyre; James Morgan; John N Baxter; Saoirse E O'Sullivan; Sarir Sarmad; David A Barrett; Stephen C Bain; Steve D Luzio; Jeffrey W Stephens Journal: J Diabetes Res Date: 2015-03-22 Impact factor: 4.011
Authors: Orison O Woolcott; Joyce M Richey; Morvarid Kabir; Robert H Chow; Malini S Iyer; Erlinda L Kirkman; Darko Stefanovski; Maya Lottati; Stella P Kim; L Nicole Harrison; Viorica Ionut; Dan Zheng; Isabel R Hsu; Karyn J Catalano; Jenny D Chiu; Heather Bradshaw; Qiang Wu; Cathryn M Kolka; Richard N Bergman Journal: PLoS One Date: 2015-04-09 Impact factor: 3.240
Authors: María T Ramírez-López; Rocío Arco; Juan Decara; Mariam Vázquez; Patricia Rivera; Rosario Noemi Blanco; Francisco Alén; Raquel Gómez de Heras; Juan Suárez; Fernando Rodríguez de Fonseca Journal: Front Behav Neurosci Date: 2016-12-27 Impact factor: 3.558
Authors: Antoni Pastor; Fernando Fernández-Aranda; Montserrat Fitó; Susana Jiménez-Murcia; Cristina Botella; Jose M Fernández-Real; Gema Frühbeck; Francisco J Tinahones; Ana B Fagundo; Joan Rodriguez; Zaida Agüera; Klaus Langohr; Felipe F Casanueva; Rafael de la Torre Journal: PLoS One Date: 2016-02-05 Impact factor: 3.240